The stock’s new peak comes after a period of sustained gains, with Asarfi Hospital trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling a strong upward trend. Despite a slight decline of -1.65% on the day, the stock remains well-positioned relative to its historical price levels.
Over the past year, Asarfi Hospital has delivered a remarkable return of 122.42%, substantially outperforming the Sensex’s 9.72% return over the same period. This performance is underscored by the stock’s 52-week low of Rs.72.9, highlighting the extent of its rally within the last twelve months.
Our latest monthly pick, this micro-cap from Hospital, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- Investment Committee approved
- 50+ candidates screened
- Strong post-announcement performance
Financially, Asarfi Hospital’s recent quarterly results reflect positive trends. Net sales reached a quarterly high of Rs.44.89 crores, while PBDIT and PBT less other income also recorded their highest quarterly figures at Rs.8.87 crores and Rs.4.89 crores respectively. These figures contribute to the stock’s upward momentum and reinforce its position within the hospital sector.
The company’s ability to service debt is evident from its Debt to EBITDA ratio of 1.44 times, indicating a manageable level of leverage. Additionally, the Return on Capital Employed (ROCE) stands at 8.6%, reflecting the company’s efficiency in generating returns from its capital base. The enterprise value to capital employed ratio of 3.3 further suggests an attractive valuation relative to its capital structure.
Despite the stock’s strong performance, the broader market context shows mixed signals. The Sensex opened 91.42 points higher but later declined by -188.77 points, currently trading at 84,853.60, which is 0.51% below its own 52-week high of 85,290.06. The Sensex remains above its 50-day moving average, with the 50 DMA positioned above the 200 DMA, indicating a generally bullish market trend.
Want to dive deeper on Asarfi Hospital ? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- Real-time research report
- Complete fundamental analysis
- Peer comparison included
Examining the company’s growth metrics, net profit has shown a rise of 34.38% in the recent quarter, with positive results declared for two consecutive quarters. Over the past year, profits have increased by 161%, a figure that significantly outpaces the stock’s price return, resulting in a PEG ratio of 0.2. This suggests that the stock’s price movement is supported by underlying profit growth.
However, some metrics indicate areas of caution. The company’s average ROCE of 8.67% points to modest profitability per unit of capital employed, while operating profit has grown at an annual rate of 14.76% over the last five years, reflecting a moderate pace of long-term growth. Institutional investors have reduced their stake by -1.04% in the previous quarter, collectively holding 2.24% of the company’s shares, which may influence market dynamics.
Asarfi Hospital’s stock has experienced a brief reversal after two consecutive days of gains, underperforming its sector by -0.49% today. Nonetheless, the stock’s position above all key moving averages and its recent all-time high underscore the strength of its current trend.
In summary, Asarfi Hospital’s attainment of a new 52-week high at Rs.193.8 marks a significant achievement in its stock performance. Supported by robust quarterly financials, manageable debt levels, and strong profit growth, the stock’s momentum reflects its standing within the hospital sector amid a cautiously optimistic market environment.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
